New Zealand vs United States: Proportion of the target population who received the final dose of
New Zealand
52.0%
in 2024
United States
52.0%
in 2024
New Zealand rank
71st
United States rank
71st
Proportion of the target population who received the final dose of over time
- New Zealand
- United States
How they compare
New Zealand currently reports 52.0% against 52.0% in United States, a difference of 0.0%.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was New Zealand ahead.
New Zealand ranks 71st and United States ranks 71st of 107 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.7% | 31.6% | 24.1% | New Zealand |
| 2020s | 57.2% | 50.8% | 6.4% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, New Zealand or United States?
- New Zealand, at 52.0% against 52.0% in United States as of 2024.
- What is the difference in proportion of the target population who received the final dose of between New Zealand and United States?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and United States?
- 15 years are reported by both, from 2010 to 2024.
- How do New Zealand and United States rank globally for proportion of the target population who received the final dose of?
- New Zealand ranks 71st and United States ranks 71st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.